LEO Pharma is progressing by leaps and bounds in the Chinese market by creating a subsidiary with the ambition of becoming the leading dermatological China.
The new company, LEO Pharma China, will market the broad portfolio of LEO Pharma of drugs protected by patents and high level for the treatment of chronic skin psoriasis and other dermatological products (pharmaceuticals for the treatment of skin diseases).
The leading brand for psoriasis LEO Pharma, Daivobet ®, has just been adopted by the Chinese authorities and can now be marketed in China.
LEO Pharma is progressing by leaps and bounds in the Chinese market by creating a subsidiary with the ambition of becoming the leading dermatological China.
The new company, LEO Pharma China, will market the broad portfolio of LEO Pharma of drugs protected by patents and high level for the treatment of chronic skin psoriasis and other dermatological products (pharmaceuticals for the treatment of skin diseases).
The leading brand for psoriasis LEO Pharma, Daivobet ®, has just been adopted by the Chinese authorities and can now be marketed in China.
Over 40 percent of cases of colon cancer and breast cancer in some countries are preventable through healthy eating patterns, physical activity and weight maintenance, according to estimates from a report that has established recommendations for policy and measures to prevent cancer.
The report, Policy and Action for Cancer Prevention, published by the World Cancer Research Fund (WCRF) and American Institute for Cancer Research (AICR), has estimated that about 43 percent of colon cancer cases and 42 percent of cases of breast cancer in the UK could be prevented in this way.
Over 40 percent of cases of colon cancer and breast cancer in some countries are preventable through healthy eating patterns, physical activity and weight maintenance, according to estimates from a report that has established recommendations for policy and measures to prevent cancer.
The report, Policy and Action for Cancer Prevention, published by the World Cancer Research Fund (WCRF) and American Institute for Cancer Research (AICR), has estimated that about 43 percent of colon cancer cases and 42 percent of cases of breast cancer in the UK could be prevented in this way.
The Max Planck Institute for Evolutionary Anthropology and the MPI-EVA 454 Life Sciences Corporation announced at the annual meeting of the American Association for the Advancement of Science (AAAS), and simultaneously at a press , which have completed the first draft of the Neanderthal genome.
The project was made possible thanks to funding from the Max Planck Society, is headed by Prof. Svante Pääbo, director of the Department of Evolutionary Genetics of the MPI-EVA. Pääbo and his colleagues have sequenced more than 1 billion pieces of DNA extracted from Neanderthal fossil from Croatia, using new methods developed for this project. The sequence of the Neanderthal genome will clarify the evolutionary relationships between humans and Neanderthals as well as help in identifying the genetic changes that enabled modern humans to leave Africa and spread around the world about 100,000 years ago.
The Max Planck Institute for Evolutionary Anthropology and the MPI-EVA 454 Life Sciences Corporation announced at the annual meeting of the American Association for the Advancement of Science (AAAS), and simultaneously at a press , which have completed the first draft of the Neanderthal genome.
The project was made possible thanks to funding from the Max Planck Society, is headed by Prof. Svante Pääbo, director of the Department of Evolutionary Genetics of the MPI-EVA. Pääbo and his colleagues have sequenced more than 1 billion pieces of DNA extracted from Neanderthal fossil from Croatia, using new methods developed for this project. The sequence of the Neanderthal genome will clarify the evolutionary relationships between humans and Neanderthals as well as help in identifying the genetic changes that enabled modern humans to leave Africa and spread around the world about 100,000 years ago.